Director Guy P. Nohra files initial Form 3 for TELA Bio (NASDAQ: TELA)

Rhea-AI Filing Summary

TELA Bio, Inc. director Guy P. Nohra has filed an initial statement of beneficial ownership on Form 3. The data provided show no reportable purchases, sales, gifts, option exercises, or other transactions, and no derivative positions listed at this time.

Key Terms

Form 3, beneficial ownership, insider

3 terms

Form 3 regulatory

"has filed an initial statement of beneficial ownership on Form 3"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"filed an initial statement of beneficial ownership on Form 3"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

insider regulatory

"reported his status as an insider at TELA Bio"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 06/11/2026 - 06:05 PM Accepted by SEC EDGAR 06/11/2026 - 06:05 PM Learn about SEC filing dates

FAQ

What does Guy P. Nohra’s Form 3 filing for TELA (TELA) represent?

The Form 3 filing shows that director Guy P. Nohra has formally reported his status as an insider at TELA Bio. It is an initial statement of beneficial ownership, providing a baseline before any future reportable transactions occur.

Does the TELA (TELA) Form 3 for Guy P. Nohra show any stock transactions?

The Form 3 data for Guy P. Nohra show no reported stock purchases, sales, gifts, or option exercises. All transaction counts and share amounts are listed as zero, indicating no reportable trading activity in this filing.

What role does Guy P. Nohra hold at TELA Bio (TELA) in this Form 3?

The Form 3 identifies Guy P. Nohra as a director of TELA Bio, Inc. Being listed as a director means he is considered an insider and must report his holdings and future transactions in company securities under SEC rules.

Are there any derivative securities reported for Guy P. Nohra in TELA (TELA) Form 3?

The filing’s derivative summary is empty, indicating no listed options, warrants, or other derivative securities for Guy P. Nohra in this Form 3. It establishes a baseline with no derivative positions reported at the time of filing.

Why is Guy P. Nohra’s TELA (TELA) Form 3 important for investors?

Form 3 is important because it establishes Guy P. Nohra’s starting beneficial ownership as a TELA Bio director. Future Forms 4 or 5 can then be compared to this baseline to track his subsequent trading or changes in holdings over time.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

NOHRA GUY P

(Last) (First) (Middle)

C/O TELA BIO, INC.

1 GREAT VALLEY PARKWAY, SUITE 24

(Street)

MALVERN PENNSYLVANIA 19355

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/09/2026

3. Issuer Name and Ticker or Trading Symbol
TELA Bio, Inc. [ TELA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Megan Smeykal, Attorney-in-Fact	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)